A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

NCT05496738 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-07264660 intravenous single ascending dose
DRUG: PF-07264660 subcutaneous multiple ascending dose
OTHER: Intravenous placebo
OTHER: subcutaneous placebo

Sponsor

Pfizer